AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
BUPARVAQUONE in Zimbabwe
5 products registered with MCAZ — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| BUTACURE SOLUTION; INJECTION | 2024/80.22.50/9842 | ASHISH LIFE SCIENCES PVT LTD | active | 25 Mar 2029 |
| BUPARLON 5% SOLUTION; INJECTION | 2025/80.22.50/9867 | HEBEI LIHUA PHARMACEUTICAL CO. LTD | active | 31 Dec 2027 |
| BUTALEX INJECTABLE; INJECTION | 87/80.22.50/9186 | INTERVET S.A (PTY) LTD | active | 31 Dec 2027 |
| BUTACHEM-50 SOLUTION; INJECTION | 2021/80.22.50/9806 | FIVET ANIMAL HEALTH | active | 31 Dec 2027 |
| BUTAZYD INJECTION SOLUTION; INJECTION | 2025/80.22.50/9869 | ZENEX ANIMAL HEALTH INDIA PRIVATE LIMITED | active | 31 Dec 2027 |
BUPARVAQUONE — MCAZ Registration Details
MCAZ (Zimbabwe) has 5 registered products containing BUPARVAQUONE, of which 5 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track BUPARVAQUONE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.